
    
      This registry is a prospective, multi-center, non-randomized post approval evaluation
      comprised of two (2) registry arms with independent hypotheses. The registry arms are defined
      as; Arm 1) physicians who perform greater than or equal to 50 atrial fibrillation ablation
      procedures per year and Arm 2) physicians who perform less than 50 atrial fibrillation
      ablation procedures per year. Subjects with drug refractory recurrent symptomatic PAF will be
      considered for this post approval registry. This registry will be conducted at up to 40
      centers in a minimum of 381 evaluable subjects. The devices are currently FDA approved for
      commercial distribution under PMA #P030031/S11.
    
  